APA (7th ed.) Citation

PR, T., JR, S., JS, I., TO, A., PV, G., JE, K., . . . PC, S. (2015). CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy. European journal of clinical pharmacology, 71(9), 1067. https://doi.org/10.1007/s00228-015-1896-x

Chicago Style (17th ed.) Citation

PR, Tomaz, Santos JR, Issa JS, Abe TO, Gaya PV, Krieger JE, Pereira AC, and Santos PC. "CYP2B6 Rs2279343 Polymorphism Is Associated with Smoking Cessation Success in Bupropion Therapy." European Journal of Clinical Pharmacology 71, no. 9 (2015): 1067. https://doi.org/10.1007/s00228-015-1896-x.

MLA (9th ed.) Citation

PR, Tomaz, et al. "CYP2B6 Rs2279343 Polymorphism Is Associated with Smoking Cessation Success in Bupropion Therapy." European Journal of Clinical Pharmacology, vol. 71, no. 9, 2015, p. 1067, https://doi.org/10.1007/s00228-015-1896-x.